City College of San Francisco

Microbiology 12

Go back

The Activity of Antimicrobial drugs

Note:

This information is NOT intended as medical advice. Before taking any medication consult with a physician.

Antiviral & antiparasitic agents will be dealt with in separate lectures.

 Terminology related to antibiotics

The Principal of Selective Toxicity

This important concept was developed by Paul Ehrlich in the early 1900's while he studied dyes that stained microbial cells but not animal (eukaryotic) cells. Ehrlich realized this selectivity could be used to develop "magic bullets" against microbial pathogens which would leave the host unharmed. Ehrlich struck his target when "compound 606," an arsenical compound called Salvarsan proved effective for the treatment of syphilis.

What is an antibiotic?

An antibiotic is a natural substance produced by microbes that inhibits or kills other microbes. Only a few useful and natural sources of antibiotics have been identified from bacteria and fungi. For example, the fungi Penicillium and Cephalosporium give rise to penicillin and cephalosporins, respectively. Species of Bacillus provide us with the antibiotics polymyxin and bacitracin. Over half of all naturally occurring antibiotics are isolated from species of Streptomyces which are common soil bacteria. Currently most mass produced antibiotics are semi-synthetic derivatives of natural compounds.

Growth factor analogs (GFAs)

These drugs are are synthetic chemicals (manufactured by us) and not naturally produced by microbes. GFAs typically act as competitive inhibitors of essential biochemical pathways. The compounds typically mimic" important building blocks needed for microbial growth but are sufficiently different that the function of the growth factor in the cell is impeded. GFAs resembling DNA bases, amino acids and vitamins are currently in use. Sulfa drugs were the first GFA's to be identified and are discussed under the section headed "antimetabolites." Other GFAs are useful for treating a variety of viral and fungal infections.

Bactericidal drugs

Act by killing bacteria.

Bacteriostatic drugs

Act to suppress or inhibit bacterial replication sufficiently until the immune system can eliminate the organisms

Prophylactic drugs

Drugs taken to prevent a disease rather than treat an established infection

Synergism

Certain drugs work better together in combination compared to being used individually.

Antagonism

 Certain drugs may decrease the effectiveness of others, or prove toxic when taken in combination.Monotherapy

Taking a single agent to treat an infection

Combination therapy

Taking more than one drug to treat an infection. This is a common strategy used to treat certain infectious disease agents that are notoriously drug resistant such as HIV and Mycobacterium tuberculosis.

Patient compliance

The ability of a patient to adhere to their drug regimen and complete a course of therapy

Spectrum of activity

Narrow spectrum drugs

 Target a particular type of microbe. Use of narrow spectrum agents is preferable for treatment of specific infections and to minimize the possibility of selecting for drug resistant organisms.

Broad spectrum drugs

Act against a wide range of microorganisms.

 


 Ideal characteristics of antibiotics

A single agent is unlikely to meet all of these criteria

Major targets of antibiotics:

Inhibitors of cell wall synthesis

1. B-lactams (Penicillins, Cephalosporins)

 Key features:

2. Vancomycin

Key features:

3. Isoniazid (INH)


Inhibitors of protein synthesis

30 S inhibitors ( Aminoglycosides, Tetracyclines)

 Aminoglycosides (Streptomycin, Kanamycin, Gentamicin)

Tetracyclines

50 S inhibitors (Erythromycin, Chloramphenicol)

 Erythromycin

 Chloramphenicol


Inhibitors of nucleic acid synthesis

Quinolones (Ciprofloxacin)

 Rifampin

Inhibitors of cell membranes

Due to similarities with human cell membranes their are fewer drugs available against this target

Polymyxins

Ergosterol inhibitors

These drugs are largely anti-fungal agents. Their selective target is ergosterol which replaces cholesterol as the major sterol component in eukaryotic cell membranes.

Two major classes of inhibitors exist:

Polyenes (include Amphotericin B, Nystatin)

Azoles (miconazole, clotrimazole, ketakonazole)

Antimetabolites

Trimethoprim and Sulfonamides

Each inhibit a particular enzyme involved in the bacterial pathway for production of tetrahydrofolic acid (THFA). THFA is an essential cofactor used in the synthesis of certain DNA and RNA bases and certain amino acids. Animal cells take in preformed folic acid in the diet and do not make their own THFA. Consequently, they are unaffected by the drugs that block the THFA pathway. The sulfonamides are structural analogs of PABA which is used by the first enzyme in the THFA pathway.